Study: NCT03305419

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GSK2982772 capsule
Description: GSK2982772 will be available as size 00, white, opaque capsule containing white to almost white Solid (120 mg maximum fill per capsule). It will be administered orally with water to receive total dose of 120 mg, 240 mg or 360 mg per randomization.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GSK2982772 capsule
Description: GSK2982772 will be available as size 00, white, opaque capsule containing white to almost white Solid (120 mg maximum fill per capsule). It will be administered orally with water to receive total dose of 120 mg, 240 mg or 360 mg per randomization.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GSK2982772 capsule
Description: GSK2982772 will be available as size 00, white, opaque capsule containing white to almost white Solid (120 mg maximum fill per capsule). It will be administered orally with water to receive total dose of 120 mg, 240 mg or 360 mg per randomization.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GSK2982772 capsule
Description: GSK2982772 will be available as size 00, white, opaque capsule containing white to almost white Solid (120 mg maximum fill per capsule). It will be administered orally with water to receive total dose of 120 mg, 240 mg or 360 mg per randomization.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GSK2982772 capsule
Description: GSK2982772 will be available as size 00, white, opaque capsule containing white to almost white Solid (120 mg maximum fill per capsule). It will be administered orally with water to receive total dose of 120 mg, 240 mg or 360 mg per randomization.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GSK2982772 capsule
Description: GSK2982772 will be available as size 00, white, opaque capsule containing white to almost white Solid (120 mg maximum fill per capsule). It will be administered orally with water to receive total dose of 120 mg, 240 mg or 360 mg per randomization.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GSK2982772 capsule
Description: GSK2982772 will be available as size 00, white, opaque capsule containing white to almost white Solid (120 mg maximum fill per capsule). It will be administered orally with water to receive total dose of 120 mg, 240 mg or 360 mg per randomization.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GSK2982772 capsule
Description: GSK2982772 will be available as size 00, white, opaque capsule containing white to almost white Solid (120 mg maximum fill per capsule). It will be administered orally with water to receive total dose of 120 mg, 240 mg or 360 mg per randomization.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo capsule
Description: Placebo will be available as size 00, white, opaque capsule containing white to almost white Solid. It will be administered orally with water.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo capsule
Description: Placebo will be available as size 00, white, opaque capsule containing white to almost white Solid. It will be administered orally with water.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo capsule
Description: Placebo will be available as size 00, white, opaque capsule containing white to almost white Solid. It will be administered orally with water.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo capsule
Description: Placebo will be available as size 00, white, opaque capsule containing white to almost white Solid. It will be administered orally with water.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo capsule
Description: Placebo will be available as size 00, white, opaque capsule containing white to almost white Solid. It will be administered orally with water.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo capsule
Description: Placebo will be available as size 00, white, opaque capsule containing white to almost white Solid. It will be administered orally with water.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo capsule
Description: Placebo will be available as size 00, white, opaque capsule containing white to almost white Solid. It will be administered orally with water.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo capsule
Description: Placebo will be available as size 00, white, opaque capsule containing white to almost white Solid. It will be administered orally with water.